Panacea Life Sciences Holdings Inc (PLSH): Alvaro Daniel Alberttis

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Re: nealhugh post# 631

Sunday, 01/19/2020 3:30:20 PM

Sunday, January 19, 2020 3:30:20 PM

Alvaro Daniel Alberttis

Keep Last Read

Replies (2) Next 10 Prev Next

Form 1-A - Offering Statement [Regulation A] • Edgar (US Regulatory) • 06/11/2024 09:12:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 12:37:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 05:40:52 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2024 01:00:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 03:28:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 07:24:23 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/08/2023 08:04:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 05:07:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 01:15:13 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2023 04:21:21 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/15/2023 03:28:18 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 03:19:11 PM
Panacea Life Sciences Holdings, Inc. Chief Scientific Officer, Dr. James Baumgartner, is Featured on The Stock Day Podcast • InvestorsHub NewsWire • 07/18/2023 04:41:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 01:00:13 PM

InvestorsHub NewsWire

Only $200 per official company press release!